Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study (original) (raw)

The efficacy and safety of tofacitinib in patients with alopecia totalis

Dogan Bayram

Journal of the American Academy of Dermatology, 2018

View PDFchevron_right

Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature

Tulin Ergun

Dermatology Online Journal, 2017

View PDFchevron_right

Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients

Zekayi Kutlubay

Dermatologic Therapy, 2019

View PDFchevron_right

Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series

Soyun Cho

Journal of the American Academy of Dermatology, 2017

View PDFchevron_right

Effective treatment of alopecia universalis with oral tofacitinib: A case report

Amnah N Almulhim

Our Dermatology Online, 2021

View PDFchevron_right

Acne exacerbation after tofacitinib treatment for alopecia areata

Mohammed G Turkmani

Dermatology Reports, 2021

View PDFchevron_right

Clinical Case of Tofacitinib Therapy in Autoimmune Alopecia in Patient with Ulcerative Colitis

Nataliya Blatt

BioNanoScience

View PDFchevron_right

Evaluation of the alopecia areata patients on tofacitinib treatment during the COVID‐19 pandemic

defne özkoca

Dermatologic Therapy, 2021

View PDFchevron_right

A Novel Hope for Alopecia Totalis Patients: Case Report

laila otaibi

Dubai Medical Journal, 2020

View PDFchevron_right

Treatment of corticosteroid-refractory alopecia totalis with oral tacrolimus

roberto verdolini

Journal of Dermatological Treatment, 2017

View PDFchevron_right

Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo

George Varigos

Clinical and experimental dermatology, 2017

View PDFchevron_right

Subcutaneous efalizumab is not effective in the treatment of alopecia areata

Ivor Caro

Journal of the American Academy of Dermatology, 2008

View PDFchevron_right

Intramuscular Corticosteroid Therapy in the Treatment of Alopecia Areata: A Time-to-Event Analysis

Poonkiat Suchonwanit

Drug Design, Development and Therapy

View PDFchevron_right

Immunotherapy for resistant and/or severe alopecia areata in a university hospital setting in Northern Mexico

Minerva Gómez-flores

Australasian Journal of Dermatology, 2019

View PDFchevron_right

Comparative Efficacy and Adverse Clinical Events of Methotrexate versus Azathioprine with Steroid Mini Pulse Therapy in the Management of Moderate to Severe Alopecia Areata: A Tertiary Centre Based Interventional Study

Chandranshu Pandey

Nepal journal of dermatology, venereology & leprology, 2022

View PDFchevron_right

Ixekizumab-induced alopecia areata

Christopher Bunick

JAAD Case Reports

View PDFchevron_right

Autoimmunity: Alopecia Areata

Marna Ericson

Journal of Investigative Dermatology Symposium Proceedings, 2004

View PDFchevron_right

From Targets to Treatments: Bridging Autoimmune Research to Advance Understanding of Alopecia Areata

David Norris

The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research, 2015

View PDFchevron_right

Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib

Abraham Zlotogorski

EBioMedicine, 2015

View PDFchevron_right

Alopecia Areata Universalis during Treatment of Rheumatoid Arthritis with Anti-TNF-α Antibody (Adalimumab)

BENOIT BENSAID

Dermatology, 2008

View PDFchevron_right

The Triumph of JAK Inhibitors for the Treatment of Alopecia Areata

Ronda Farah

International Society of Hair Restoration Surgery

View PDFchevron_right

Management of alopecia areata: an update

Abid Keen

2012

View PDFchevron_right

Multiple courses of pulse corticosteroid therapy for alopecia areata

fukumi furukawa

The Journal of Dermatology, 2016

View PDFchevron_right

Successful Therapy of Alopecia Universalis Using a Combination of Systemic Methotrexate and Corticosteroids and Topical 5% Minoxidil

Erda Avriyanti

Clinical, Cosmetic and Investigational Dermatology, 2022

View PDFchevron_right

Frequency of Alopecia Areata with other autoimmune disorders

Nauman aziz

The Professional Medical Journal, 2022

View PDFchevron_right

Advances in the management of alopecia areata

Taisuke Ito

The Journal of dermatology, 2012

View PDFchevron_right

Relapse in Alopecia Totalis after Successful Treatment with Intralesional Corticosteroid and Oral Immunomodulator

Lili Legiawati

Journal of Skin and Stem Cell

View PDFchevron_right

Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata

N. Andreu

British Journal of Dermatology, 2018

View PDFchevron_right

Alopecia Areata: An Autoimmune Disease of Multiple Players

Boong.chaninan Kositkuljorn

ImmunoTargets and Therapy, 2021

View PDFchevron_right

Oral Pulse Betamethasone, Methotrexate, and Combination Therapy to Treat Severe Alopecia Areata: A Randomized, Double-blind, Placebo-controlled, Clinical Trial

fatemeh mohaghegh

Iranian Journal of Pharmaceutical Research : IJPR, 2021

View PDFchevron_right

The Efficacy of Intermittant Low-Dose Systemic Corticosteroid in the Treatment of Alopecia Areata

Emel Ozturk

TURKISH …, 2004

View PDFchevron_right

Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update

Poonkiat Suchonwanit

Drug Design, Development and Therapy

View PDFchevron_right